Abstract
To establish that bradykinin is formed in the heart we measured bradykinin in the venous effluent from rat isolated hearts perfused with Krebs-Henseleit buffer. In addition, we examined the effect on bradykinin outflow of the angiotensin converting enzyme (ACE) inhibitor, ramiprilat. From rat isolated normoxic hearts a bradykinin outflow of 0.85 +/- 0.1 ng ml-1 perfusate g-1 wet weight was measured. Perfusion with ramiprilat increased the bradykinin concentration to 2.8 +/- 0.3 ng ml-1 perfusate g-1 wet weight. During ischaemia bradykinin outflow maximally increased 8.2 fold to 7.0 +/- 0.5 ng ml-1 perfusate g-1, and in ramiprilat-perfused hearts 5.8 fold to 16.0 +/- 1.8 ng ml-1 perfusate g-1. In the reperfusion period bradykinin outflow normalized to values measured in the respective pre-ischaemic period. The presents data show that bradykinin is continuously formed in the rat isolated heart. Ischaemia increases bradykinin outflow from the heart. Presumably by inhibiting degradation of kinins, ACE inhibition significantly increased the bradykinin concentration during normoxia, ischaemia and reperfusion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hashimoto K., Hamamoto H., Honda Y., Hirose M., Furukawa S., Kimura E. Changes in components of kinin system and hemodynamics in acute myocardial infarction. Am Heart J. 1978 May;95(5):619–626. doi: 10.1016/0002-8703(78)90304-6. [DOI] [PubMed] [Google Scholar]
- Hashimoto K., Hirose M., Furukawa S., Hayakawa H., Kimura E. Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Jpn Heart J. 1977 Sep;18(5):679–689. doi: 10.1536/ihj.18.679. [DOI] [PubMed] [Google Scholar]
- Johnston C. I., Mooser V., Sun Y., Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol. 1991 Feb;18(2):107–110. doi: 10.1111/j.1440-1681.1991.tb01417.x. [DOI] [PubMed] [Google Scholar]
- Linz W., Schölkens B. A. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992 Apr;105(4):771–772. doi: 10.1111/j.1476-5381.1992.tb09054.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martorana P. A., Linz W., Schölkens B. A. Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors? Basic Res Cardiol. 1991 Jul-Aug;86(4):293–296. doi: 10.1007/BF02191526. [DOI] [PubMed] [Google Scholar]
- Matsuki T., Shoji T., Yoshida S., Kudoh Y., Motoe M., Inoue M., Nakata T., Hosoda S., Shimamoto K., Yellon D. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res. 1987 Jun;21(6):428–432. doi: 10.1093/cvr/21.6.428. [DOI] [PubMed] [Google Scholar]
- Proud D., Togias A., Naclerio R. M., Crush S. A., Norman P. S., Lichtenstein L. M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov;72(5):1678–1685. doi: 10.1172/JCI111127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaper W., Görge G., Winkler B., Schaper J. The collateral circulation of the heart. Prog Cardiovasc Dis. 1988 Jul-Aug;31(1):57–77. doi: 10.1016/0033-0620(88)90011-4. [DOI] [PubMed] [Google Scholar]
- Schunkert H., Dzau V. J., Tang S. S., Hirsch A. T., Apstein C. S., Lorell B. H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990 Dec;86(6):1913–1920. doi: 10.1172/JCI114924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiemer G., Schölkens B. A., Becker R. H., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991 Oct;18(4):558–563. doi: 10.1161/01.hyp.18.4.558. [DOI] [PubMed] [Google Scholar]